Literature DB >> 28670081

Treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma presenting simultaneously with acquired hemophilia and warm autoimmune hemolytic anemia.

Chelsea Williams1, Christian Cable1, Julia Choi1.   

Abstract

Since both acquired factor VIII inhibitor in non-hemophiliac patients and warm autoimmune hemolytic anemia are uncommon disorders with no case-controlled trials, managing these diseases can be challenging. We present a case of a 75-year-old man in whom both diseases were present simultaneously with life-threatening bleeding. This case is an example of the successful initial management and long-term treatment of acquired hemophilia A, warm autoimmune hemolytic anemia, and chronic lymphocytic leukemia/small lymphocytic lymphoma with rituximab, prednisone, and cyclophosphamide.

Entities:  

Year:  2017        PMID: 28670081      PMCID: PMC5468039          DOI: 10.1080/08998280.2017.11929642

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  9 in total

Review 1.  Acquired hemophilia a: diagnosis, aetiology, clinical spectrum and treatment options.

Authors:  Shrimati Shetty; Manali Bhave; Kanjaksha Ghosh
Journal:  Autoimmun Rev       Date:  2010-11-27       Impact factor: 9.754

2.  Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).

Authors:  Peter Collins; Francesco Baudo; Paul Knoebl; Hervé Lévesque; László Nemes; Fabio Pellegrini; Pascual Marco; Lilian Tengborn; Angela Huth-Kühne
Journal:  Blood       Date:  2012-04-18       Impact factor: 22.113

Review 3.  How I manage patients with acquired haemophilia A.

Authors:  Douglas W Sborov; George M Rodgers
Journal:  Br J Haematol       Date:  2013-02-04       Impact factor: 6.998

Review 4.  Acquired factor VIII inhibitors.

Authors:  Massimo Franchini; Giuseppe Lippi
Journal:  Blood       Date:  2008-05-07       Impact factor: 22.113

Review 5.  Autoimmune cytopenias in chronic lymphocytic leukemia.

Authors:  Carlo Visco; Wilma Barcellini; Francesco Maura; Antonino Neri; Agostino Cortelezzi; Francesco Rodeghiero
Journal:  Am J Hematol       Date:  2014-07-07       Impact factor: 10.047

Review 6.  The anti-CD20 monoclonal antibody rituximab to treat acquired haemophilia A.

Authors:  Giovanni D'arena; Elvira Grandone; Matteo N D Di Minno; Pellegrino Musto; Giovanni Di Minno
Journal:  Blood Transfus       Date:  2015-09-03       Impact factor: 3.443

Review 7.  Acquired factor VIII inhibitors in oncohematology: a systematic review.

Authors:  Massimo Franchini; Giovanni Targher; Franco Manzato; Giuseppe Lippi
Journal:  Crit Rev Oncol Hematol       Date:  2008-02-19       Impact factor: 6.312

Review 8.  Treatment Options for Primary Autoimmune Hemolytic Anemia: A Short Comprehensive Review.

Authors:  Abdulgabar Salama
Journal:  Transfus Med Hemother       Date:  2015-08-10       Impact factor: 3.747

9.  Diagnosis and treatment of autoimmune hemolytic anemia: classic approach and recent advances.

Authors:  Sang Hyuk Park
Journal:  Blood Res       Date:  2016-06-23
  9 in total
  1 in total

1.  Hemorrhagic pericardial effusion as the debut of acquired hemophilia in a chronic lymphocytic leukemia patient: A case report, and a review of acquired hemophilia A-related hematological malignancies.

Authors:  José María Bastida; María Teresa Cano-Mozo; Felix Lopez-Cadenas; Victor Eduardo Vallejo; Soraya Merchán; Cecilia Santos-Montón; David González-Calle; Javier Carrillo; Ana Africa Martín; Jose Angel Torres-Hernández; Marcos González; Francisco Martín-Herrero; Pedro Pabón; Jose Ramon González-Porras
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.